PitchSend

BenevolentAI Investor Presentation Deck

BenevolentAl's target discovery tools and process identifies promising, novel therapeutic targets TECH APPROACH PREDICT TRIAGE ΤΡΑ ASSAY 1. Define the Tech Approach Using our in-house tools and algorithms we explore the data and define the input to our predictive models Disease Target ↓ Can we treat ALS by reversing Autophagy impairment in microglia by reducing oxidative stress? 3. Triage and Assess Progressibility Our tools aggregate and present the necessary data for scientific decision- making, progressing only the most promising hypotheses. Sign Pow/3E120 Search Qey Fer Tog Mechanism Cha T2D CARMI Une PDK1 ULK1 NR1H3 T detay1guaHmember 3 Endpoint: What we are measuring in the assay S Cell type CU 250 P2 • G 2. Target Prediction Our Al algorithms, data queries, and endotype-driven workflows identify targets that are likely to address the tech approach. Graph Models Transcriptomics Models Precision Medicine Genetics Precision Medicine 'Omics Data queries Large Language Model Aggregation Prioritization Targets 4. Validate Experimentally Targets sent to a series of mechanistic and disease-relevant assays to assess a target's potential. Benevolent 37

View entire presentation